CME / ABIM MOC / CE

Breast Cancer Risk Assessment and Screening

Authors: Elizabeth A. Morris, MD; Heather Hampel, MS, CGC; Stamatia Destounis, MD; Wendy DeMartini, MD; Janice S. Sung, MD; Jessica W. T. Leung, MD, FACR, FSBI
CME / ABIM MOC / CE Released: 11/30/2022
Valid for credit through: 11/30/2023

Credits Available

Physicians - maximum of 2.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates - maximum of 2.50 ABIM MOC points

Nurses - 2.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

Radiologic Technologists – maximum of 3.5 hours of ARRT Category A continuing education credit

You Are Eligible For
- Letter of Completion
- ABIM MOC points

Target Audience and Goal Statement

This activity is intended for radiologists, radiologic technologists, hematologists/oncologists, and pathologists.

The goal of this activity is for the learner to be better able to assess patients who may be at increased risk for breast cancer.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Criteria used to determine if a patient should be assessed for increased risk of breast cancer
- Models used to assess breast cancer risk
- Relationship between breast density and breast cancer risk
- Predictive value of BI-RADS®
- Role of contrast-enhanced mammography in breast cancer screening
Demonstrate greater confidence in their ability to
- Assess patients at increased risk for breast cancer

Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.

Faculty

Elizabeth A. Morris, MD

Professor and Chair, Department of Radiology
University of California
Davis School of Medicine
Sacramento, California

Disclosures

Elizabeth A. Morris, MD, has no relevant financial relationships.

Heather Hampel, MS, CGC

Licensed Genetic Counselor
Division of Clinical Cancer Genomics
City of Hope
Duarte, California

Disclosures

Heather Hampel, MS, CGC, has the following relevant financial relationships:
Consultant or advisor for: 23andMe; Genome Medical; Invitae Genetics; Promega

Stamatia Destounis, MD

Chair, ACR Breast Commission
Managing Partner/Owner
Elizabeth Wende Breast Care
Rochester, New York

Disclosures

Stamatia Destounis, MD, has the following relevant financial relationships:
Research funding from: Hologic, Inc.
Monetary compensation for an executive role from: Medical Advisory board member for iCAD, Inc.

Wendy DeMartini, MD

Professor
Chief, Breast Imaging Division
Department of Radiology
Stanford University School of Medicine
Stanford, California

Disclosures

Wendy DeMartini, MD, has the following relevant financial relationships:
Consultant or advisor for: Kheiron Medical Technologies
Speaker or member of speakers bureau for: Whiterabbit.ai

Janice S. Sung, MD

Department of Radiology
Memorial Sloan Kettering Cancer Center
New York, New York

Disclosures

Janice S. Sung, MD, has the following relevant financial relationships:
Research funding from: GE Healthcare

Jessica W. T. Leung, MD, FACR, FSBI

Professor of Diagnostic Radiology
Deputy Chair, Department of Breast Imaging
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Disclosures

Jessica W. T. Leung, MD, FACR, FSBI, has the following relevant financial relationships:
Consultant or advisor for: Bracco; Guerbet; Seno Medical; Subtle Medical
Speaker or member of speakers bureau for: GE Healthcare; Hologic
Owns stock (publicly traded) in: GE Healthcare; Hologic

Editor

Victoria Phoenix, BS

Medical Education Director, Medscape, LLC

Disclosures

Victoria Phoenix, BS, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For Nurses

Awarded 2.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Radiology

CME / ABIM MOC / CE

Breast Cancer Risk Assessment and Screening

Authors: Elizabeth A. Morris, MD; Heather Hampel, MS, CGC; Stamatia Destounis, MD; Wendy DeMartini, MD; Janice S. Sung, MD; Jessica W. T. Leung, MD, FACR, FSBIFaculty and Disclosures

CME / ABIM MOC / CE Released: 11/30/2022

Valid for credit through: 11/30/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Individualized Breast Cancer Risk Assessment

Do you know how risk calculation for breast cancer can vary depending on the risk assessment model used?
Heather Hampel, MS, CGC

Implications of Density in Breast Cancer Risk

Do you know the effect on risk calculation when breast density is added as a factor?
Stamatia Destounis, MD, FACR

Clinical Application and Predictive Value of the Breast Imaging Reporting and Data System (BI-RADS®)

Is your breast cancer screening practice in line with the US Screening Benchmarks?
Wendy DeMartini, MD

What's New in Mammography?

Have you thought about offering contrast-enhanced mammography in your practice?
Janice S. Sung, MD

Standard Mammography vs Breast MRI for Screening

When and how are you using MRI for breast cancer screening?
Jessica W.T. Leung, MD, FACR, FSBI

Patient Handout

Patient Handout 2

Educational Impact Challenge

The goal of this activity is for the learner to be better able to assess patients who may be at increased risk for breast cancer.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

Page 1 of 8

CME / ABIM MOC / CE Information Download Slides

PDF Downloads

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Elizabeth A. Morris, MD

Heather Hampel, MS, CGC

Stamatia Destounis, MD

Wendy DeMartini, MD

Janice S. Sung, MD

Jessica W. T. Leung, MD, FACR, FSBI

Editor

Victoria Phoenix, BS

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

CME / ABIM MOC / CE

Breast Cancer Risk Assessment and Screening

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Elizabeth A. Morris, MD

Heather Hampel, MS, CGC

Stamatia Destounis, MD

Wendy DeMartini, MD

Janice S. Sung, MD

Jessica W. T. Leung, MD, FACR, FSBI

Editor

Victoria Phoenix, BS

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Breast Cancer Risk Assessment and Screening

Contents of This CME Activity

Individualized Breast Cancer Risk Assessment

Implications of Density in Breast Cancer Risk

Clinical Application and Predictive Value of the Breast Imaging Reporting and Data System (BI-RADS®)

What's New in Mammography?

Standard Mammography vs Breast MRI for Screening

Patient Handout Patient Handout 2

Educational Impact Challenge

PDF Downloads

Patient Handout

Patient Handout 2